China Medical System (867.HK; 8A8.SG) Signed Collaboration Agreements for Two Innovative Biologics Used for Passive Immunization Against Tetanus and Rabies China Medical System Holdings Limited Sep 23, 2025 12:15 HKT/SGT Read More
康哲药业就用于破伤风被动免疫和狂犬病被动免疫的两款创新生物制剂达成合作 China Medical System Holdings Limited Sep 23, 2025 11:16 HKT/SGT Read More
康哲藥業就用於破傷風被動免疫和狂犬病被動免疫的兩款創新生物製劑達成合作 China Medical System Holdings Limited Sep 23, 2025 11:16 HKT/SGT Read More
EASD 2025 | HighTide Therapeutics Announces Oral Presentation of Phase 3 Data in Patients with Type 2 Diabetes HighTide Therapeutics Inc. Sep 17, 2025 08:00 HKT/SGT Read More
EASD 2025 | 君聖泰醫藥口頭報告HTD1801治療2型糖尿病臨床3期研究成果 HighTide Therapeutics Inc. Sep 17, 2025 08:00 HKT/SGT Read More
EASD 2025 | 君圣泰医药口头报告HTD1801治疗2型糖尿病临床3期研究成果 HighTide Therapeutics Inc. Sep 17, 2025 08:00 HKT/SGT Read More
HKTDC releases research report on biomedicine, Industry development drives GBA global tech leadership HKTDC Sep 15, 2025 15:19 HKT/SGT Read More
Eisai Presents Clinical Study Results of Novel Orexin Receptor Agonist E2086 for Narcolepsy at World Sleep 2025 Eisai Sep 08, 2025 16:49 HKT/SGT Read More
Eisai to Present Latest Data on Lemborexant and Novel Orexin Receptor Agonist E2086 at The World Sleep 2025 Eisai Sep 04, 2025 09:56 HKT/SGT Read More
FDA Approves LEQEMBI(R) IQLIK(TM) (lecanemab-irmb) Subcutaneous Injection for Maintenance Dosing for the Treatment of Early Alzheimer's Disease Eisai Sep 01, 2025 12:44 HKT/SGT Read More
Resilient Interim Results, Essex Bio-Technology Drives Growth and Innovation Essex Bio-Technology Limited Aug 26, 2025 20:00 HKT/SGT Read More
Austria and Germany to become the first markets in the European Union (EU) to launch LEQEMBI(R) (lecanemab) Eisai Aug 25, 2025 18:30 HKT/SGT Read More
NMPA Accepted Essex's Biologics License Application for EB12-20145P (HLX04-O) for the Treatment of Wet Age-Related Macular Degeneration Essex Bio-Technology Limited Aug 13, 2025 20:24 HKT/SGT Read More
Innovative Vaccine Engine Continues to Drive Growth: CanSinoBIO Enters a New Growth Cycle CanSino Biologics Inc Aug 20, 2025 20:30 HKT/SGT Read More
CMS (867.HK, 8A8.SG) Reports Growth in Revenue and Profit for H1 2025, Strategic Transformation Unlocks New Drivers China Medical System Holdings Limited Aug 19, 2025 16:00 JST Read More
CMS (867.HK, 8A8.SG) Reports Growth in Revenue and Profit for H1 2025, Strategic Transformation Unlocks New Drivers China Medical System Holdings Limited Aug 19, 2025 15:00 HKT/SGT Read More
康哲藥業(867.HK,8A8.SG)上半年營收淨利雙升 戰略轉型跑出增長新動能 China Medical System Holdings Limited Aug 19, 2025 11:53 HKT/SGT Read More
康哲药业(867.HK,8A8.SG)上半年营收净利双升 战略转型跑出增长新动能 China Medical System Holdings Limited Aug 19, 2025 11:53 HKT/SGT Read More
UNFPA and NEC Collaborate to Build Beneficiary Information Management and e-Voucher System NEC Corporation Aug 18, 2025 13:38 HKT/SGT Read More
NMPA已受理亿胜生物关于EB12-20145P(HLX04-O)用于治疗湿性年龄相关性黄斑变性的生物制品许可申请 Essex Bio-Technology Limited Aug 13, 2025 21:25 HKT/SGT Read More